Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Clinical trial NCT03038022 · COMPLETED
Trial details
- NCT number
- NCT03038022
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-23
- Primary completion
- 2018-01-15
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.